3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasm Metastasis
5
Lymphoma
4
Breast Neoplasms
4
Ovarian Neoplasms
3
Multiple Myeloma
3
Lymphoma, Large B-Cell, Diffuse
3
Endometrial Neoplasms
3
Urinary Bladder Neoplasms
2
Thyroid Neoplasms
2
Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Colonic Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid cancer, follicular
1
Thyroid Cancer, Papillary
1
Stomach Neoplasms
1
Spinocerebellar Degenerations
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Melanoma
1
Malignant Solid Neoplasm
1
Lymphoma, Mantle-Cell
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Interventions
Gemcitabine
33
Cisplatin
28
pembrolizumab
19
durvalumab
17
Oxaliplatin
16
Fluorouracil
16
Leucovorin
14
Magnetic Resonance Spectroscopy
13
Specimen Handling
9
Biopsy
9
lenvatinib
7
Nivolumab
7
Capecitabine
7
Taxes
6
Paclitaxel
6
Irinotecan
6
fludarabine
5
Folfox protocol
5
Drug Therapy
5
Carboplatin
5
Albumin-Bound Paclitaxel
5
pemigatinib
4
Ipilimumab
4
Fluorodeoxyglucose F18
4
Floxuridine
4
Cyclophosphamide
4
Bevacizumab
4
130-nm albumin-bound paclitaxel
4
tremelimumab
3
olaparib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cholangiocarcinoma
×
copanlisib
×
1 year
×
Clear all
No trials found.